| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |